EUVIMED · CrossrefZeitschrift
Kidney Cancer
ISSN 2468-4562 · SAGE Publications
Neueste Artikel
Prognostic Value of Histologic Subtype and Treatment Modality for T1a Kidney Cancers
Surgical approaches following durable responses to immunotherapy
Introduction to updates in kidney tumor classification, morphology, and molecular alterations in Kidney Cancer
Clinical trials corner: Take a BiTE out of kidney cancer
Role of immune check point inhibitor rechallenge in metastatic renal cell carcinoma
Spatial clustering of immunosuppressive macrophages in papillary renal cell carcinoma
Assessing genetic and urologic providers on renal screening recommendations for individuals with a familial renal cancer risk
Pragmatic trials in renal cell carcinoma
Renal biopsy in the era of immune-based combination therapies for metastatic renal cell carcinoma: Current practices and considerations
A Review: Novel Therapies for Advanced Clear Cell Renal Cell Carcinoma
The role of ablative therapy for primary and oligometastatic renal cell carcinoma
Von Hippel Lindau syndrome: A systematic review of pharmaceutical treatments
Microbiome in RCC – A systematic review of the literature
Development and characterisation of a large animal transgenic tumor model for sarcomatoid renal cell carcinoma
Liquid biopsy for renal cell carcinoma: A comprehensive review of techniques, applications, and future prospects
The role of checkpoint inhibitor rechallenge in patients with metastatic renal cell carcinoma: A systematic review
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials
External validation of automated CT volumetry in renal tumor volume measurement and its surgical implications
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma
A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma
Kidney Cancer Incidence in California: End of the Trend?
Therapeutic Sequencing in Metastatic Renal Cell Carcinoma
Association of Circulating Tumor DNA (ctDNA) Detection in Metastatic Renal Cell Carcinoma (mRCC) with Tumor Burden
Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice
Systematic Review: Perioperative Systemic Therapy for Metastatic Renal Cell Carcinoma
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC—A Possible Path Forward
Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges
Tissue Expression of Erythropoietin Predicts Survival Rates in Clear Cell Renal Cell Carcinoma
Translating Metabolic Reprogramming into New Targets for Kidney Cancer
EUVIMED